You are here

Spineology Receives FDA Clearance for Rampart™ Interbody Fusion System

ST. PAUL, Minn. (Nov 1, 2011) — Spineology Inc., the innovator in anatomy-conserving spine surgery™, announced today that it has received FDA clearance for, and is initiating launch of, the new Rampart™ line of Interbody fusion implants. The Rampart line will include a variety of implant configurations, lengths, and heights providing the surgeon with several options to fit patient needs. The Rampart System is further configured with implantation equipment designed toenhance the surgeon’s ability to position the implant within the disc space. “Spineology is committed to developing the implant solutions our customers desire,” said John Booth, CEO for Spineology. “Rampart is a great synergistic fitfor our growing product line.”